Home Healthcare Biotechnology Inhaled Biologics Market

Inhaled Biologics Market Size, Share & Trends Analysis Report By Type (Peptides and Proteins, Vaccines, Monoclonal Antibodies, RNAi-based Therapeutics, Others), By Application (Respiratory diseases, Diabetes, Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Inhaled Biologics Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Peptides and Proteins
    2. Vaccines
    3. Monoclonal Antibodies
    4. RNAi-based Therapeutics
    5. Others
  2. Inhaled Biologics Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Respiratory diseases
      1. COPD
      2. Asthma
      3. Cystic Fibrosis
      4. Others
    2. Diabetes
    3. Cancer
    4. Others
  3. Inhaled Biologics Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
  4. Regional Inhaled Biologics Market
    1. North America
      1. North America Inhaled Biologics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
      2. North America Inhaled Biologics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        2. Diabetes
        3. Cancer
        4. Others
      3. North America Inhaled Biologics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. U.S.
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      5. Canada
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
    2. Europe
      1. Europe Inhaled Biologics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
      2. Europe Inhaled Biologics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        2. Diabetes
        3. Cancer
        4. Others
      3. Europe Inhaled Biologics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. U.K.
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      5. Germany
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      6. France
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      7. Spain
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      8. Italy
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      9. Russia
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      10. Nordic
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      11. Benelux
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      12. Rest of Europe
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
    3. APAC
      1. APAC Inhaled Biologics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
      2. APAC Inhaled Biologics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        2. Diabetes
        3. Cancer
        4. Others
      3. APAC Inhaled Biologics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. China
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      5. Korea
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      6. Japan
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      7. India
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      8. Australia
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      9. Taiwan
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      10. South East Asia
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      11. Rest of Asia-Pacific
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Inhaled Biologics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
      2. Middle East and Africa Inhaled Biologics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        2. Diabetes
        3. Cancer
        4. Others
      3. Middle East and Africa Inhaled Biologics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. UAE
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      5. Turkey
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      6. Saudi Arabia
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      7. South Africa
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      8. Egypt
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      9. Nigeria
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      10. Rest of MEA
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
    5. LATAM
      1. LATAM Inhaled Biologics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
      2. LATAM Inhaled Biologics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        2. Diabetes
        3. Cancer
        4. Others
      3. LATAM Inhaled Biologics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. Brazil
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      5. Mexico
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      6. Argentina
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      7. Chile
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      8. Colombia
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
      9. Rest of LATAM
        1. Peptides and Proteins
        2. Vaccines
        3. Monoclonal Antibodies
        4. RNAi-based Therapeutics
        5. Others
        6. Respiratory diseases
          1. COPD
          2. Asthma
          3. Cystic Fibrosis
          4. Others
        7. Diabetes
        8. Cancer
        9. Others
        10. Hospital Pharmacies
        11. Retail Pharmacies
        12. Online Pharmacies
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.